Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sarcoidosis and the nervous system.

A W Heck1, L H Phillips

  • 1Department of Neurology, University of Virginia Health Sciences Center, Charlottesville.

Neurologic Clinics
|August 1, 1989
PubMed
Summary

Sarcoidosis can affect the nervous system (neurosarcoidosis), often presenting with cranial nerve issues like facial nerve palsy. While central nervous system involvement has a poorer prognosis, early treatment with corticosteroids offers hope for many patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and electrophysiological findings in the migrant sensory 'neuritis' of wartenberg.

Journal of clinical neuromuscular disease·2008
Same author

What's in the Literature?

Journal of clinical neuromuscular disease·2008
Same author

What's in the Literature?

Journal of clinical neuromuscular disease·2008
Same author

Motor neuron disease and serum monoclonal proteins: poor response to treatment of the paraproteinemia.

Journal of clinical neuromuscular disease·2008
Same author

What's in the Literature?

Journal of clinical neuromuscular disease·2008
Same author

What's in the literature?

Journal of clinical neuromuscular disease·2008

Area of Science:

  • Neurology
  • Immunology
  • Systemic Inflammatory Diseases

Background:

  • Sarcoidosis is a multisystem inflammatory disease.
  • Neurologic involvement (neurosarcoidosis) affects approximately 5% of patients.
  • Neurologic symptoms can be the initial presentation in half of affected individuals.

Purpose of the Study:

  • To review the presentation, diagnosis, and management of neurosarcoidosis.
  • To highlight the varied manifestations and prognoses of neurologic involvement in sarcoidosis.

Main Methods:

  • Review of existing literature on neurosarcoidosis.
  • Analysis of clinical presentations, diagnostic criteria, and treatment outcomes.

Main Results:

  • Neurologic symptoms result from a granulomatous process similar to systemic sarcoidosis.
  • Cranial nerves, particularly the facial nerve, are most commonly affected with a good prognosis.
  • Central nervous system involvement, often meningoencephalitis, is typically chronic and associated with a poor prognosis.
  • Peripheral nerve and muscle involvement can be asymptomatic or present subacutely/chronically.

Conclusions:

  • Diagnosis relies on systemic evidence of sarcoidosis supported by clinical and laboratory findings.
  • Corticosteroids are the primary treatment, with anecdotal evidence of efficacy.
  • While early acute presentations have good outcomes, chronic CNS disease poses a significant challenge.

Related Experiment Videos